- Home
- QLYS vs OPCH Comparison
QLYS vs OPCH Comparison
Compare QLYS & OPCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | QLYS | OPCH |
|---|---|---|
| Founded | 1999 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Medical/Nursing Services |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.3B | 4.9B |
| IPO Year | 2012 | 1996 |
Fundamental Metrics
Financial Performance| Metric | QLYS | OPCH |
|---|---|---|
| Price | $96.61 | $29.67 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 13 | 9 |
| Target Price | ★ $137.46 | $37.44 |
| AVG Volume (30 Days) | 793.2K | ★ 1.9M |
| Earning Date | 05-07-2026 | 05-22-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 16.99 | 3.25 |
| EPS | ★ 5.44 | 1.27 |
| Revenue | $321,607,000.00 | ★ $4,998,202,000.00 |
| Revenue This Year | $9.96 | $7.53 |
| Revenue Next Year | $7.15 | $8.58 |
| P/E Ratio | ★ $18.14 | $23.50 |
| Revenue Growth | 15.32 | ★ 16.17 |
| 52 Week Low | $85.14 | $24.24 |
| 52 Week High | $155.47 | $36.80 |
Technical Indicators
Market Signals| Indicator | QLYS | OPCH |
|---|---|---|
| Relative Strength Index (RSI) | 36.24 | 28.70 |
| Support Level | $85.14 | $29.23 |
| Resistance Level | $136.70 | $31.14 |
| Average True Range (ATR) | 4.63 | 1.27 |
| MACD | 1.51 | -0.53 |
| Stochastic Oscillator | 56.84 | 13.12 |
Price Performance
Historical ComparisonAbout QLYS Qualys Inc.
Qualys is a cloud security and compliance solutions provider that helps businesses identify and manage their security risks and compliance requirements. The California-based company has more than 10,000 customers worldwide, the majority of which are small- and medium-size businesses. Qualys was founded in 1999 and went public in 2012.
About OPCH Option Care Health Inc.
Option Care Health Inc is the provider of home and alternate-site infusion services. It provides treatment for bleeding disorders, neurological disorders, heart failure, anti-infectives, and chronic inflammatory disorders, among others. The Company operates in one segment, infusion services.